Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Gains from Investment Securities (2022 - 2026)

HeartSciences filings provide 5 years of Gains from Investment Securities readings, the most recent being $467.0 for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities fell 99.6% to $467.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $467.0, a 99.6% decrease, with the full-year FY2025 number at $173659.0, up 13509.64% from a year prior.
  • Gains from Investment Securities hit $467.0 in Q1 2026 for HeartSciences, down from $604000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.1 million in Q4 2023 to a low of $467.0 in Q1 2026.
  • Median Gains from Investment Securities over the past 5 years was $117000.0 (2025), compared with a mean of $228307.2.
  • Biggest five-year swings in Gains from Investment Securities: surged 10970.38% in 2025 and later crashed 99.6% in 2026.
  • HeartSciences' Gains from Investment Securities stood at $251942.0 in 2022, then skyrocketed by 324.05% to $1.1 million in 2023, then tumbled by 99.49% to $5456.0 in 2024, then surged by 10970.38% to $604000.0 in 2025, then tumbled by 99.92% to $467.0 in 2026.
  • The last three reported values for Gains from Investment Securities were $467.0 (Q1 2026), $604000.0 (Q4 2025), and $2756.0 (Q3 2025) per Business Quant data.